New research has discovered a unique and promising avenue for diagnosing Alzheimer’s disease (AD) earlier—by analyzing AD biomarkers in blood—so that the impacts of dementia can be reduced.
New research has discovered a unique and promising avenue for diagnosing Alzheimer’s disease (AD) earlier—by analyzing AD biomarkers in blood—so that the impacts of dementia can be reduced.